Biden Looks to Slash Drug Prices By Going After Big Pharma's Monopolies
The administration is hoping to address competition issues by curbing price hikes on name-brand drugs and limiting the power of patent holders. Read→
Previous
Previous
FDA Kicks Multiple Vape Companies Out of U.S. Market, JUUL Could Follow
Next
Next